Milestone Scientific Stock Cash And Equivalents

MLSS Stock

USD 1.21 0.01 0.83%

Milestone Scientific fundamentals help investors to digest information that contributes to Milestone Scientific's financial success or failures. It also enables traders to predict the movement of Milestone Stock. The fundamental analysis module provides a way to measure Milestone Scientific's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Milestone Scientific stock.

Short Long Term Debt Total Total Assets

This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Milestone Scientific Company Cash And Equivalents Analysis

Milestone Scientific's Cash or Cash Equivalents are the most liquid of all assets found on the company's balance sheet. It is used in calculating many of the firm's liquidity ratios and is a good indicator of the overall financial health of a company. Companies with a lot of cash are usually attractive takeover targets. Cash Equivalents are balance sheet items that are typically reported using currency printed on notes.

Cash

Bank Deposits

+

Liquidities

More About Cash And Equivalents | All Equity Analysis

Current Milestone Scientific Cash And Equivalents

9.81 M

Most of Milestone Scientific's fundamental indicators, such as Cash And Equivalents, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Milestone Scientific is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

Milestone Cash And Equivalents Driver Correlations

Understanding the fundamental principles of building solid financial models for Milestone Scientific is extremely important. It helps to project a fair market value of Milestone Stock properly, considering its historical fundamentals such as Cash And Equivalents. Since Milestone Scientific's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Milestone Scientific's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Milestone Scientific's interrelated accounts and indicators.

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Accounts Payable	Net Receivables	Total Liab	Total Current Assets	Short Term Debt	Intangible Assets	Common Stock	Treasury Stock	Property Plant Equipment	Current Deferred Revenue	Net Tangible Assets	Total Permanent Equity	Long Term Debt Total	Capital Surpluse	Short Long Term Debt	Net Invested Capital	Net Working Capital	Capital Stock
Total Assets		0.95	-0.88	-0.45	-0.36	0.17	0.14	0.98	-0.03	-0.09	0.38	0.04	0.53	0.32	0.71	0.67	0.03	0.56	0.45	0.72	0.71	0.37
Total Stockholder Equity	0.95		-0.93	-0.34	-0.42	-0.06	-0.19	0.94	-0.18	-0.2	0.35	0.04	0.6	0.1	0.74	0.61	0.03	0.53	0.32	0.78	0.77	0.4
Net Debt	-0.88	-0.93		0.37	0.46	0.08	0.16	-0.88	0.18	0.26	-0.34	-0.15	-0.57	0.01	-0.62	-0.55	0.13	-0.51	-0.29	-0.76	-0.77	-0.36
Retained Earnings	-0.45	-0.34	0.37		0.23	0.15	-0.33	-0.56	0.07	0.59	-0.87	0.33	-0.62	-0.11	-0.68	-0.47	-0.37	-0.84	-0.72	-0.32	-0.44	-0.79
Accounts Payable	-0.36	-0.42	0.46	0.23		0.18	0.22	-0.41	0.12	-0.13	-0.42	0.06	-0.55	-0.23	-0.4	-0.33	-0.09	-0.54	-0.4	-0.31	-0.38	-0.43
Net Receivables	0.17	-0.06	0.08	0.15	0.18		0.72	0.12	0.67	0.53	-0.42	0.39	-0.55	0.74	-0.37	0.24	-0.37	-0.29	0.21	-0.34	-0.4	-0.6
Total Liab	0.14	-0.19	0.16	-0.33	0.22	0.72		0.11	0.53	0.3	0.09	0.02	-0.21	0.7	-0.12	0.17	0.0	0.09	0.46	-0.21	-0.2	-0.11
Total Current Assets	0.98	0.94	-0.88	-0.56	-0.41	0.12	0.11		0.0	-0.23	0.48	0.01	0.59	0.29	0.74	0.75	0.08	0.67	0.58	0.66	0.69	0.46
Short Term Debt	-0.03	-0.18	0.18	0.07	0.12	0.67	0.53	0.0		0.27	-0.28	0.25	-0.31	0.56	-0.34	0.16	-0.24	-0.18	0.35	-0.34	-0.36	-0.45
Intangible Assets	-0.09	-0.2	0.26	0.59	-0.13	0.53	0.3	-0.23	0.27		-0.52	0.28	-0.36	0.6	-0.43	-0.23	-0.29	-0.44	-0.19	-0.18	-0.28	-0.53
Common Stock	0.38	0.35	-0.34	-0.87	-0.42	-0.42	0.09	0.48	-0.28	-0.52		-0.63	0.82	0.05	0.8	0.37	0.63	0.87	0.63	0.43	0.56	0.94
Treasury Stock	0.04	0.04	-0.15	0.33	0.06	0.39	0.02	0.01	0.25	0.28	-0.63		-0.39	0.0	-0.52	-0.09	-0.92	-0.29	-0.12	-0.12	-0.18	-0.53
Property Plant Equipment	0.53	0.6	-0.57	-0.62	-0.55	-0.55	-0.21	0.59	-0.31	-0.36	0.82	-0.39		-0.02	0.84	0.26	0.39	0.8	0.51	0.75	0.83	0.87
Current Deferred Revenue	0.32	0.1	0.01	-0.11	-0.23	0.74	0.7	0.29	0.56	0.6	0.05	0.0	-0.02		0.07	0.35	0.0	0.09	0.54	-0.09	-0.11	-0.13
Net Tangible Assets	0.71	0.74	-0.62	-0.68	-0.4	-0.37	-0.12	0.74	-0.34	-0.43	0.8	-0.52	0.84	0.07		0.57	0.53	0.74	0.43	0.67	0.72	0.8
Total Permanent Equity	0.67	0.61	-0.55	-0.47	-0.33	0.24	0.17	0.75	0.16	-0.23	0.37	-0.09	0.26	0.35	0.57		0.16	0.49	0.55	0.07	0.12	0.27
Long Term Debt Total	0.03	0.03	0.13	-0.37	-0.09	-0.37	0.0	0.08	-0.24	-0.29	0.63	-0.92	0.39	0.0	0.53	0.16		0.45	0.24	0.12	0.18	0.61
Capital Surpluse	0.56	0.53	-0.51	-0.84	-0.54	-0.29	0.09	0.67	-0.18	-0.44	0.87	-0.29	0.8	0.09	0.74	0.49	0.45		0.78	0.48	0.6	0.91
Short Long Term Debt	0.45	0.32	-0.29	-0.72	-0.4	0.21	0.46	0.58	0.35	-0.19	0.63	-0.12	0.51	0.54	0.43	0.55	0.24	0.78		0.15	0.26	0.54
Net Invested Capital	0.72	0.78	-0.76	-0.32	-0.31	-0.34	-0.21	0.66	-0.34	-0.18	0.43	-0.12	0.75	-0.09	0.67	0.07	0.12	0.48	0.15		0.99	0.52
Net Working Capital	0.71	0.77	-0.77	-0.44	-0.38	-0.4	-0.2	0.69	-0.36	-0.28	0.56	-0.18	0.83	-0.11	0.72	0.12	0.18	0.6	0.26	0.99		0.64
Capital Stock	0.37	0.4	-0.36	-0.79	-0.43	-0.6	-0.11	0.46	-0.45	-0.53	0.94	-0.53	0.87	-0.13	0.8	0.27	0.61	0.91	0.54	0.52	0.64

Click cells to compare fundamentals

Cash equivalents represent current assets that are easily convertible to cash such as short term bonds, savings account, money market funds, or certificate of deposits (CDs). One of the important consideration companies make when classifying assets as cash equivalent is that investments they report on their balance sheets under current assets should have almost no risk of change in value over the next few months (usually three months).

Competition

Predict Milestone Scientific

Milestone Cash And Cash Equivalents Changes

Cash And Cash Equivalents Changes

15.34 Million

At this time, Milestone Scientific's Cash And Cash Equivalents Changes is comparatively stable compared to the past year.

In accordance with the recently published financial statements, Milestone Scientific has 9.81 M in Cash And Equivalents. This is 98.8% lower than that of the Health Care Equipment & Supplies sector and 96.88% lower than that of the Health Care industry. The cash and equivalents for all United States stocks is 99.64% higher than that of the company.

Milestone Cash And Equivalents Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Milestone Scientific's direct or indirect competition against its Cash And Equivalents to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Milestone Scientific could also be used in its relative valuation, which is a method of valuing Milestone Scientific by comparing valuation metrics of similar companies.

Milestone Scientific is currently under evaluation in cash and equivalents category among its peers.

Milestone Scientific Current Valuation Drivers

We derive many important indicators used in calculating different scores of Milestone Scientific from analyzing Milestone Scientific's financial statements. These drivers represent accounts that assess Milestone Scientific's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Milestone Scientific's important valuation drivers and their relationship over time.

	2020	2021	2022	2023	2024	2025 (projected)
Market Cap	133.7M	141.8M	33.9M	50.2M	57.7M	54.9M
Enterprise Value	120.4M	127.6M	25.7M	47.6M	54.8M	52.0M

Milestone Fundamentals

	Return On Equity	-0.65
	Return On Asset	-0.38
	Profit Margin	(0.52) %
	Operating Margin	(0.58) %
	Current Valuation	89.79 M
	Shares Outstanding	77.89 M
	Shares Owned By Insiders	22.91 %
	Shares Owned By Institutions	5.69 %
	Number Of Shares Shorted	135.11 K
	Price To Earning	(6.39) X
	Price To Book	13.05 X
	Price To Sales	10.62 X
	Revenue	9.83 M
	Gross Profit	6.43 M
	EBITDA	(6.96 M)
	Net Income	(6.93 M)
	Cash And Equivalents	9.81 M
	Cash Per Share	0.14 X
	Total Debt	395.98 K
	Debt To Equity	0.05 %
	Current Ratio	3.95 X
	Book Value Per Share	0.09 X
	Cash Flow From Operations	(5.33 M)
	Short Ratio	0.50 X
	Earnings Per Share	(0.06) X
	Target Price	2.13
	Number Of Employees	17
	Beta	1.14
	Market Capitalization	94.25 M
	Total Asset	11.37 M
	Retained Earnings	(123.34 M)
	Working Capital	7.72 M
	Current Asset	10.74 M
	Current Liabilities	4.4 M
	Net Asset	11.37 M

About Milestone Scientific Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Milestone Scientific's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Milestone Scientific using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Milestone Scientific based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Please read more on our fundamental analysis page.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Milestone Stock Analysis

When running Milestone Scientific's price analysis, check to measure Milestone Scientific's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Milestone Scientific is operating at the current time. Most of Milestone Scientific's value examination focuses on studying past and present price action to predict the probability of Milestone Scientific's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Milestone Scientific's price. Additionally, you may evaluate how the addition of Milestone Scientific to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC